Prolonged response of relapsed high grade serous ovarian carcinoma to the oral angiokinase inhibitor nintedanib in a patient with a germline BRCA1 mutation

► Nintedanib is an anti-angiogenic agent that has demonstrated activity in relapsed ovarian cancer. ► Our patient had prolonged response to nintedanib, allowing her to have potentially curative surgery 6 years after her diagnosis. ► The relationship between angiogenesis and BRCA mutation is worth ex...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Wong, Han Hsi, Parkinson, Christine, Ledermann, Jonathan A., Brenton, James D., Merger, Michael, Shaw, Ashley, Patterson, Aileen, Shafi, Mahmood, Earl, Helena M.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Elsevier 2012
Θέματα:
Case Report
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3862224/
https://ncbi.nlm.nih.gov/pubmed/24371652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gynor.2012.10.003
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια